-
Views
-
Cite
Cite
Andrea V. Page, Phillip I. Tarr, Sandra L. Watkins, Nimerta Rajwans, Tania N. Petruzziello-Pellegrini, Philip A. Marsden, Kevin C. Kain, W. Conrad Liles, Dysregulation of Angiopoietin 1 and 2 in Escherichia coli O157:H7 Infection and the Hemolytic-Uremic Syndrome, The Journal of Infectious Diseases, Volume 208, Issue 6, 15 September 2013, Pages 929–933, https://doi.org/10.1093/infdis/jit268
- Share Icon Share
Abstract
Escherichia coli O157:H7-associated hemolytic-uremic syndrome (HUS) is characterized by profound prothrombotic abnormalities. Endothelial dysfunction, manifested as dysregulation of angiopoietins 1 and 2 (Ang-1/2), could underlie HUS pathophysiology. We measured Ang-1/2 in 77 children with E. coli O157:H7 infection. Ang-1, Ang-2, and the Ang-2/Ang-1 ratio were significantly different in HUS vs the pre-HUS phase of illness or uncomplicated infection. Angiopoietin dysregulation preceded HUS and worsened as HUS developed. In vitro exposure of human microvascular endothelial cells to Shiga toxin recapitulated the in vivo observations. Angiopoietin regulation is profoundly affected before and during HUS, reflecting that subclinical endothelial dysfunction precedes overt microangiopathy.